Michael Leek
Vorstandsvorsitzender bei TCB Newco Ltd.
Aktive Positionen von Michael Leek
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Vorstandsvorsitzender | - | - |
| Vorsitzender | - | - | |
| Gründer | - | - |
Karriereverlauf von Michael Leek
Ehemalige bekannte Positionen von Michael Leek
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Vorstandsvorsitzender | 01.01.2013 | 01.06.2021 |
| Vorsitzender | 01.01.2013 | 14.02.2023 | |
| Technik-/Wissenschafts-/F&E-Leiter | 14.02.2023 | 01.06.2023 | |
| Gründer | 01.01.2013 | 01.06.2023 | |
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Geschäftsführer | 01.01.2000 | 03.02.2006 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Vorstandsvorsitzender | 01.01.2014 | - |
| Gründer | 01.01.2014 | - |
Ausbildung von Michael Leek
| University of Leeds | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 6 |
Operativ
| Chief Executive Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Intercytex Ltd.
Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Börse
- Insiders
- Michael Leek
- Erfahrung
